Therapeutic amprenavir concentrations in cerebrospinal fluid (Q35867483)

10 August 2017

Therapeutic amprenavir concentrations in cerebrospinal fluid (English)

1 reference

10 August 2017

0 references

Ronald J Ellis

5

0 references

Igor Grant

series ordinal

16

object named as

Igor Grant

1 reference

10 August 2017

2

Scott Letendre

1 reference

10 August 2017

12

Susan Morgello

1 reference

10 August 2017

17

CHARTER Group

1 reference

10 August 2017

11

J Allen McCutchan

1 reference

10 August 2017

9

Christina M Marra

1 reference

10 August 2017

8

Benjamin B Gelman

1 reference

10 August 2017

10

Justin McArthur

1 reference

10 August 2017

3

Brookie M Best

1 reference

10 August 2017

1

David Croteau

1 reference

10 August 2017

14

Lauren Way

1 reference

10 August 2017

15

Edmund Capparelli

1 reference

10 August 2017

7

Ann C Collier

1 reference

10 August 2017

Steven S Rossi

4

1 reference

10 August 2017

David B Clifford

series ordinal

6

1 reference

10 August 2017

David M Simpson

series ordinal

13

1 reference

10 August 2017

language of work or name

English

0 references

publication date

30 January 2012

1 reference

Antimicrobial Agents and Chemotherapy

10 August 2017

1 reference

10 August 2017

56

1 reference

10 August 2017

1985-1989

1 reference

10 August 2017

4

1 reference

HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318381

The complexities of antiretroviral drug-drug interactions: role of ABC and SLC transporters

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318381

Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318381

Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318381

The transport of anti-HIV drugs across blood-CNS interfaces: summary of current knowledge and recommendations for further research.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318381

Low atazanavir concentrations in cerebrospinal fluid

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318381

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318381

Lopinavir concentrations in cerebrospinal fluid exceed the 50% inhibitory concentration for HIV.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318381

Natural variation of drug susceptibility in wild-type human immunodeficiency virus type 1

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318381

Pharmacokinetic study of human immunodeficiency virus protease inhibitors used in combination with amprenavir

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318381

Indinavir population pharmacokinetics in plasma and cerebrospinal fluid. The HIV Neurobehavioral Research Center Group

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318381

Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318381

Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318381

Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318381

Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318381

Changes in cognition during antiretroviral therapy: comparison of 2 different ranking systems to measure antiretroviral drug efficacy on HIV-associated neurocognitive disorders

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318381

Quantitative assessment of HIV-1 protease inhibitor interactions with drug efflux transporters in the blood-brain barrier.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318381

Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318381

Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318381

Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318381

Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318381

Viral response in stable patients switching to fosamprenavir/ritonavir monotherapy (the FONT Study)

24 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22290964

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.05098-11

1 reference

10 August 2017

1 reference

10 August 2017

1 reference